An immunogenic anti-cancer stem cell bi-nuclear copper( ii )-flufenamic acid complex
Dalton Transactions · 2024
DOI: 10.1039/d4dt00384e ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2024. Verfasst von Yue Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry, University of Leicester, Leicester, LE1 7RH, UK. k.suntharalingam@leicester.ac.uk. Hauptthemen laut MEDLINE: Coordination Complexes, Antineoplastic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Engineering and Physical Sciences Research Council.
Abstract (Originalsprache)
An asymmetric bi-nuclear copper( ii ) complex with both cytotoxic and immunogenic activity towards breast cancer stem cells (CSCs) is reported.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry, University of Leicester, Leicester, LE1 7RH, UK. k.suntharalingam@leicester.ac.uk.
Förderung
- Engineering and Physical Sciences Research Council
Zitieren
APA
Li, Y., Fang, J., Singh, K., Ortu, F., & Suntharalingam, K. (2024). An immunogenic anti-cancer stem cell bi-nuclear copper( ii )-flufenamic acid complex. Dalton Transactions. https://doi.org/10.1039/d4dt00384e
Vancouver
Li Y, Fang J, Singh K, Ortu F, Suntharalingam K. An immunogenic anti-cancer stem cell bi-nuclear copper( ii )-flufenamic acid complex. Dalton Transactions. 2024. doi:10.1039/d4dt00384e
BibTeX
@article{Li2024,
author = {Li, Yue and Fang, Jiaxin and Singh, Kuldip and Ortu, Fabrizio and Suntharalingam, Kogularamanan},
title = {An immunogenic anti-cancer stem cell bi-nuclear copper( ii )-flufenamic acid complex},
journal = {Dalton Transactions},
year = {2024},
doi = {10.1039/d4dt00384e}
}
EUVIMED